Evidence map›Paper›PMID 39180090›Full record

ArticleJournal of medical case reports2024

A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report.

Melanie Berger, Falk Schumacher, Maximilian Wollsching-Strobel, Doreen Kroppen, Sarah B Stanzel, Daniel S Majorski, Kathrin Fricke, Ilka Plath, Wolfram Windisch, Maximilian Zimmermann

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melanie BergerDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany. bergerme@kliniken-koeln.de.
Falk SchumacherDepartment Humanmedizin, Universität Witten/Herdecke, Witten, Germany.
Maximilian Wollsching-StrobelDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Doreen KroppenDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Sarah B StanzelDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Daniel S MajorskiDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Kathrin FrickeDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Ilka PlathDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Wolfram WindischDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.
Maximilian ZimmermannDepartment of Pneumology, Faculty of Health/School of Medicine, Cologne Merheim Hospital, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.ORCID http://orcid.org/0000-0002-6219-5013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVEXAS syndrome, characterized by a UBA1 gene mutation, is a rare and severe systemic inflammatory disease predominantly affecting men. Since its initial description in 2020, it has been noted for its broad clinical phenotype and frequent misdiagnosis. CASE PRESENTATION: A 76-year-old Caucasian male patient diagnosed with VEXAS syndrome is presented in this case report. He presented with typical symptoms including pulmonary manifestations (infiltrates and effusions), systemic inflammation, and haematological abnormalities. The diagnosis was challenging due to the disease's heterogeneous presentation, often resembling autoimmune or haematological diseases. This patient's case featured ground-glass opacities and pleural effusions, underlining the significant pulmonary involvement seen in 50-67% of VEXAS patients. His condition was further complicated by recurrent fever and systemic inflammation affecting multiple organs.

conclusionVEXAS syndrome demands an aggressive treatment approach due to its high mortality rate and refractory nature. This case underscores the importance of including VEXAS syndrome in differential diagnoses, particularly for patients with systemic inflammation and pulmonary symptoms, and calls for multidisciplinary management and extensive research to understand its full range of clinical phenotypes.

Indexed as

PhenotypePleural EffusionUbiquitin-Activating EnzymesAgedDiagnosis, DifferentialHumansInflammationMaleMutationUBA1 protein, humanUbiquitin-Activating EnzymesPulmonary involvementSystemic diseaseUBA1 geneVEXAS syndrome

Identifiers

PMID39180090
PMCPMC11344313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.